SG127801A1 - New phenylpyridinylpiperazine compounds, a processfor their preparation and pharmaceutical composit ions containing them - Google Patents

New phenylpyridinylpiperazine compounds, a processfor their preparation and pharmaceutical composit ions containing them

Info

Publication number
SG127801A1
SG127801A1 SG200603045A SG200603045A SG127801A1 SG 127801 A1 SG127801 A1 SG 127801A1 SG 200603045 A SG200603045 A SG 200603045A SG 200603045 A SG200603045 A SG 200603045A SG 127801 A1 SG127801 A1 SG 127801A1
Authority
SG
Singapore
Prior art keywords
phenylpyridinylpiperazine
processfor
compounds
preparation
new
Prior art date
Application number
SG200603045A
Other languages
English (en)
Inventor
Patrice Desos
Alexis Cordi
Pierre Lestage
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of SG127801A1 publication Critical patent/SG127801A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
SG200603045A 2005-05-12 2006-05-05 New phenylpyridinylpiperazine compounds, a processfor their preparation and pharmaceutical composit ions containing them SG127801A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0504758A FR2885616B1 (fr) 2005-05-12 2005-05-12 Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
SG127801A1 true SG127801A1 (en) 2006-12-29

Family

ID=35668833

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200603045A SG127801A1 (en) 2005-05-12 2006-05-05 New phenylpyridinylpiperazine compounds, a processfor their preparation and pharmaceutical composit ions containing them

Country Status (25)

Country Link
US (1) US7494994B2 (ja)
EP (1) EP1721897A1 (ja)
JP (1) JP2006316061A (ja)
KR (1) KR100807481B1 (ja)
CN (1) CN100569767C (ja)
AP (1) AP2007004223A0 (ja)
AR (1) AR054121A1 (ja)
AU (1) AU2006201994A1 (ja)
BR (1) BRPI0601773A (ja)
CA (1) CA2546392A1 (ja)
CR (1) CR9499A (ja)
EA (1) EA011155B1 (ja)
FR (1) FR2885616B1 (ja)
GE (1) GEP20084470B (ja)
GT (1) GT200700097A (ja)
IL (1) IL186862A0 (ja)
MA (1) MA28326A1 (ja)
MY (1) MY141784A (ja)
NO (1) NO20062083L (ja)
NZ (1) NZ547122A (ja)
SG (1) SG127801A1 (ja)
TN (1) TNSN07395A1 (ja)
UA (1) UA87284C2 (ja)
WO (1) WO2006120349A1 (ja)
ZA (1) ZA200603810B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236259A1 (en) * 2002-02-05 2003-12-25 Rolf Hohlweg Novel aryl- and heteroarylpiperazines
BRPI0613564A2 (pt) * 2005-07-04 2011-01-18 Novo Nordisk As compostos, seus usos na preparação de composições farmacêuticas e composições farmacêuticas compreendendo os mesmos
SG163547A1 (en) * 2006-05-29 2010-08-30 High Point Pharmaceuticals Llc 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
SG177207A1 (en) * 2006-12-14 2012-01-30 Janssen Pharmaceutica Nv Process for the preparation of piperazinyl and diazepanyl benzamide derivatives
EP2014656A3 (en) 2007-06-11 2011-08-24 High Point Pharmaceuticals, LLC New heteocyclic h3 antagonists
CA2826792A1 (en) 2011-02-23 2012-08-30 Lupin Limited Heteroaryl derivatives as alpha7 nachr modulators
WO2013132380A1 (en) 2012-03-06 2013-09-12 Lupin Limited Thiazole derivatives as alpha 7 nachr modulators
EP3373935B1 (en) * 2015-11-12 2021-09-01 Merck Sharp & Dohme Corp. Cyanopyridine derivatives as liver x receptor beta agonists, compositions, and their use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0361489A3 (en) * 1988-09-30 1991-06-12 Chugai Seiyaku Kabushiki Kaisha Novel 3,4-diaminoquinoline and pyridine compounds
EP0548291A1 (en) * 1990-09-13 1993-06-30 Smithkline Beecham Corporation Pyridylthio or pyridyloxy alkanoic acids
HUP0000090A3 (en) * 1996-10-04 2002-01-28 Novo Nordisk As 1,4-disubstituted piperazines, pharmaceutical compositions containing them, process for producing them and their use
WO1999018077A1 (fr) * 1997-10-02 1999-04-15 Eisai Co., Ltd. Derives de pyridine condenses
RU2205179C2 (ru) * 1997-10-27 2003-05-27 НьюроСёрч А/С Производное гомопиперазина и фармацевтическая композиция
GB9919776D0 (en) * 1998-08-31 1999-10-27 Zeneca Ltd Compoujnds
US20030236259A1 (en) * 2002-02-05 2003-12-25 Rolf Hohlweg Novel aryl- and heteroarylpiperazines

Also Published As

Publication number Publication date
CR9499A (es) 2008-02-20
EP1721897A1 (fr) 2006-11-15
CN100569767C (zh) 2009-12-16
US20060258670A1 (en) 2006-11-16
MA28326A1 (fr) 2006-12-01
NZ547122A (en) 2007-05-31
IL186862A0 (en) 2008-02-09
BRPI0601773A (pt) 2007-05-15
CA2546392A1 (fr) 2006-11-12
TNSN07395A1 (en) 2009-03-17
EA200600760A1 (ru) 2006-12-29
AR054121A1 (es) 2007-06-06
GT200700097A (es) 2009-06-04
UA87284C2 (ru) 2009-07-10
FR2885616B1 (fr) 2007-06-22
ZA200603810B (en) 2007-08-29
GEP20084470B (en) 2008-08-25
AP2007004223A0 (en) 2007-10-31
FR2885616A1 (fr) 2006-11-17
US7494994B2 (en) 2009-02-24
NO20062083L (no) 2006-11-13
AU2006201994A1 (en) 2006-11-30
MY141784A (en) 2010-06-30
KR20060117263A (ko) 2006-11-16
CN1896073A (zh) 2007-01-17
WO2006120349A1 (fr) 2006-11-16
JP2006316061A (ja) 2006-11-24
KR100807481B1 (ko) 2008-02-25
EA011155B1 (ru) 2009-02-27

Similar Documents

Publication Publication Date Title
IL205071A (en) Its azulcarboxamide or salt compound, a pharmaceutical product containing it and its uses
GB0501999D0 (en) Pharmaceutical compounds
GB0520657D0 (en) Pharmaceutical compounds
GB0520656D0 (en) Pharmaceutical compounds
ZA200802947B (en) Stable pharmaceutical composition comprising a pyrimidine-sulfamide
AP2384A (en) 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them.
SG127801A1 (en) New phenylpyridinylpiperazine compounds, a processfor their preparation and pharmaceutical composit ions containing them
IL184562A (en) Polymorph ivandront a, a process for its preparation and pharmaceutical preparations containing it
IL187713A0 (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
ZA200800368B (en) New pharmaceutical compounds
EP1916251A4 (en) ERIANINE SALTS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HK1096386A1 (en) Indanyl-piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
IL186538A0 (en) Pharmaceutical compositions containing roflumilast
GB0512643D0 (en) Pharmaceutical compounds
SG127800A1 (en) New phenylpyridinylpiperazine compounds, a processfor their preparation and pharmaceuticals composi tions containing them
HK1093986A1 (en) Piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
SG126789A1 (en) Multi function sitck-on for face respiratory pieces
ZA200800833B (en) New 1H-indole-pyridinecarboxamide and 1H-indolepiperidinecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them
EP1864664A4 (en) PHARMACEUTICAL PREPARATION
ZA200705612B (en) Pharmaceutical compounds
GB0501475D0 (en) Pharmaceutical compounds
TWI368614B (en) Araminone compounds, their preparations, pharmaceutical compositions containing them, and their uses
GB0501480D0 (en) Pharmaceutical compounds
GB0501998D0 (en) Pharmaceutical compounds
GB0510252D0 (en) Pharmaceutical compounds